MedPath

Effectiveness of Memantine in improvement of cognitive deficits in specific learning disorder

Phase 2
Conditions
specific learning disorder.
Developmental disorder of scholastic skills, unspecified
Registration Number
IRCT2015102124633N1
Lead Sponsor
Vice Chancellor for research of Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
94
Inclusion Criteria

age 8-12 years diagnosed patients by physician specialty pure LD; no organic disorders, psychotic, mood, anxiety and combined, have normal intelligence More than 85
Exclusion criteria: mental retardation, organic problems (auditory, visual, etc.); psychotic problems, a disorder ADHD; a Pervasive Developmental Disorder, not wanting to continue treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sustained attention. Timepoint: Before treatment and after treatment. Method of measurement: Continuous Performance Test.
Secondary Outcome Measures
NameTimeMethod
Working memory. Timepoint: Before treatment and after treatment. Method of measurement: Stroop test.
© Copyright 2025. All Rights Reserved by MedPath